Titan Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 1.97%37.250.9%$1862.14m
ABBVAbbVie, Inc. 0.67%104.901.9%$1053.65m
JNJJohnson & Johnson 0.38%144.230.7%$1042.81m
BMYBristol-Myers Squibb Co. 0.35%63.061.0%$690.36m
MRKMerck & Co., Inc. -0.21%79.890.7%$680.02m
LLYEli Lilly & Co. 2.00%147.651.1%$659.48m
AZNAstraZeneca Plc 0.02%52.611.2%$313.94m
GSKGlaxoSmithKline Plc -0.42%37.080.2%$225.00m
NVSNovartis AG 0.63%89.740.2%$178.51m
NVONovo Nordisk A/S 2.13%67.550.1%$95.66m
RGENRepligen Corp. 3.07%186.997.1%$94.93m
ARCTArcturus Therapeutics Holdings, Inc. 25.35%76.000.0%$77.61m
SNYSanofi 1.85%51.130.2%$72.29m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 2.21%91.600.0%$67.14m
RPRXRoyalty Pharma Plc 1.54%41.600.2%$66.73m

Company Profile

Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.